Compare Align Technology, Inc. (ALGN) vs Oracle Corporation (ORCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Oracle Corporation — how do they compare? Align Technology, Inc. trades at $174.5 (market cap $12.36B), while Oracle Corporation trades at $153.14 (market cap $441.52B). The key difference: Oracle Corporation is far larger — about 35.7× Align Technology, Inc.'s market cap, and Oracle Corporation pays a 1.3% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | ORCL | |
|---|---|---|
Market Cap | $12.36B | $441.52B |
Sector | Health | Technology |
52-Week High | $197.51 | $328.33 |
52-Week Low | $124.88 | $114.99 |
Enterprise Value | $11.38B | $570.77B |
Dividend Yield | — | 1.3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $174.63, down 0.8% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with record revenue and clear aligner volume. Fundamentals show solid profitability with a 68.05% gross margin and 9.99% net income margin, though revenue growth has moderated. Recent news highlights a patent win in China and strategic initiatives following activist investor engagement.
The outlook is mixed: analyst consensus is strongly bullish (73% buy ratings), but technicals and slowing revenue growth pose near-term risks. Investment opportunity lies in international expansion and digital dentistry platform growth, while risks include competitive pressures and execution of new strategic initiatives. The stock's valuation at 30x P/E requires sustained earnings growth to justify.
Oracle Corporation (ORCL) trades at $145.45, down 3.7% today, as the stock faces technical bearish pressure despite strong fundamental performance. The company has consistently beaten earnings expectations in recent quarters with Q1 2026 EPS of $2.11 versus $1.96 expected, while revenue growth accelerated to $57.4 billion in 2025. Analyst sentiment remains overwhelmingly positive with 65% buy ratings and a $252.44 consensus price target, though technical indicators show bearish momentum with RSI levels above 70 suggesting overbought conditions.
Oracle presents a compelling investment case driven by AI infrastructure expansion and consistent earnings beats, but faces near-term technical headwinds and high valuation multiples. The stock's 39.9% May surge reflects AI optimism, though current levels require careful risk management given the bearish technical setup and elevated P/E ratio of 24.95.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Oracle Corporation
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Read more on ORCL →
